The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT). Issue 1 (December 2015)

Record Type:: Journal Article
Title:: The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT). Issue 1 (December 2015)
Main Title:: The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
Authors:: Huntgeburth, Michael
Kießling, Johannes
Weimann, Gerrit
Kiepsel, Verena
Saleh, Soundos
Hunzelmann, Nicolas
Rosenkranz, Stephan
Abstract:
Is Part Of:: BMC pharmacology & toxicology. Volume 16:Issue 1(2015)
Journal:: BMC pharmacology & toxicology
Issue:: Volume 16:Issue 1(2015)
Issue Display:: Volume 16, Issue 1 (2015)
Year:: 2015
Volume:: 16
Issue:: 1
Issue Sort Value:: 2015-0016-0001-0000
Page Start:: 1
Page End:: 2
Publication Date:: 2015-12
Subjects:: Pharmacology -- Periodicals
Toxicology -- Periodicals
615.105
Journal URLs:: http://www.biomedcentral.com/bmcpharmacoltoxicol ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2050-6511-16-S1-A58 ↗
Languages:: English
ISSNs:: 2050-6511
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 10062.xml